Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis. [electronic resource]
Producer: 20140424Description: 549-58 p. digitalISSN:- 1535-4989
- Aminophenols -- pharmacology
- Aminopyridines -- pharmacology
- Animals
- Benzamides -- pharmacology
- Bronchi -- drug effects
- Bronchitis, Chronic -- drug therapy
- Cells, Cultured
- Cyclic AMP
- Cyclopropanes -- pharmacology
- Cystic Fibrosis Transmembrane Conductance Regulator -- agonists
- Diarrhea -- chemically induced
- Dose-Response Relationship, Drug
- Epithelial Cells -- drug effects
- Humans
- Intestinal Secretions -- metabolism
- Intestine, Small -- drug effects
- Membrane Potentials
- Mice
- Mucociliary Clearance -- drug effects
- Phosphodiesterase 4 Inhibitors -- pharmacology
- Quinolones -- pharmacology
- Smoke -- adverse effects
- Smoking -- adverse effects
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.